Two Sigma Securities’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$646K Buy
+3,412
New +$506K 0.06% 471
2026
Q1
Sell
-9,333
Closed -$750K 1604
2025
Q4
$750K Buy
+9,333
New +$781K 0.1% 258
2025
Q3
Sell
-3,295
Closed -$230K 1335
2025
Q2
$230K Buy
+3,295
New +$188K 0.03% 836
2024
Q1
Sell
-5,079
Closed -$605K 2892
2023
Q4
$659K Buy
5,079
+914
+22% +$126K 0.01% 1338
2023
Q3
$679K Buy
+4,165
New +$733K 0.01% 1296

Other funds holding ACLS

Two Sigma Securities's ACLS Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Axcelis (ACLS) in Q2 2026: 3,412 shares worth $646K. The stake represents 0.06% of the portfolio and ranks #471 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in ACLS as recently as Q4 2025.

Two Sigma Securities first reported a position in ACLS in Q3 2023 and has held it in 5 quarters since. The position peaked at $750K in Q4 2025. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Two Sigma Securities held 3,412 shares of Axcelis worth $646K as of Q2 2026.
  • Axcelis was a new Two Sigma Securities position in Q2 2026.
  • Axcelis made up 0.06% of Two Sigma Securities's portfolio in Q2 2026, its #471 holding.
  • Two Sigma Securities first reported a position in Axcelis in Q3 2023 and has held it in 5 quarters since.
  • Two Sigma Securities's Axcelis position peaked at $750K in Q4 2025.
  • 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.